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Detection rates of congenital heart disease in Guatemala
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Abstract Objectives: In developing countries, congenital heart disease is often unrecognised, leading to serious
morbidity and mortality. Guatemala is one of the few developing countries where expert paediatric cardiac
treatment is available and affordable, and therefore early detection could significantly improve outcome. We
assessed regional congenital heart disease detection rates in Guatemala, and determined whether they
correlated with the regional human development index. Methods: We retrospectively reviewed all new cardiac
referrals made in 2006 to the Unidad de Cirugia Cardiovascular Pediatrica, the only paediatric cardiac centre
in Guatemala. We calculated regional detection rates by comparing the number of congenital heart disease
referrals with the expected incidence using the National Ministry of Health birth data. We then compared the
regional detection rates with the human development index data published in the United Nations 2006
Development Program Report using Spearman’s rank correlation. Results: An estimated 3935 infants with
cardiac defects were born in Guatemala in 2006, an expected 1380 (35%) of whom had severe forms. Overall,
only 533 children (14%) with cardiac defects were referred. Of these, 62% had simple shunt lesions, 13% had
cyanotic lesions, and 10% had left-sided obstructive lesions. Only 11.5% of referred patients were neonates.
Regional detection rates, ranged 3.2–34%, correlated with the regional human development index (r5 0.75,
p, 0.0001). Conclusions: Current detection of congenital heart disease in Guatemala is low and correlates
with the regional human development index. Those detected are older and have less severe forms, suggesting a
high mortality rate among Guatemalan neonates with complex cardiac defects.
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C
ONGENITAL HEART DISEASE IS THE MOST COMMON
form of birth defect, occurring in approxi-
mately 1% of live births.1–4 In developing
countries, congenital heart disease may go unrecog-
nised, resulting in serious morbidity and high
mortality rates.5 Each year, as many as 15 million
children in the developing world die or suffer
devastating consequences secondary to treatable or
preventable cardiac disease.6
Guatemala is one of the few developing countries
where specialised congenital heart disease treatment
is available and affordable. In 1997, the Unidad de
Cirugia Cardiovascular Pediatrica (Pediatric Cardio-
vascular Unit of Guatemala) was built in Guatemala
City. The Unidad is the only comprehensive
paediatric cardiac unit in Central America, the only
referral centre for the treatment of congenital heart
disease in Guatemala, and the only institution in
Guatemala where paediatric cardiac surgery is
performed. Furthermore, this treatment is available
at the Unidad at no or low cost.
Since its inception, the Unidad’s surgical volume
has grown quickly. From 67 surgeries performed in
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1997, the Unidad currently performs 500 surgeries
per year, placing it on a par with large paediatric
cardiac surgery programmes in the United States. In
addition, surgical outcomes at the Unidad have
improved significantly in a short period of time.7
This improvement was maintained during a transi-
tion from none to 95% of surgical procedures being
performed by locally trained surgeons, thus estab-
lishing the Unidad as a self-sustaining unit.
Despite these great strides, surgical treatment
of neonatal and complex congenital heart disease
in Guatemala remains limited.8 Fewer than 25%
of the patients undergo surgery at younger than
the age of 1 year, and 60% of the procedures are
performed on patients with simple shunt lesions.
The low percentage of neonatal and complex
surgeries compared to the percentage in developed
nations9 suggests that many of these patients die
before reaching the Unidad. However, at present,
the state of congenital heart disease detection in
Guatemala is unknown and the best tools for
studying congenital heart disease detection in
underserved populations remain unclear.
A useful tool in the study of underserved
populations is the human development index,
developed in 1990 by the United Nations. The
human development index is a composite measure
of life expectancy, literacy, education, and standard
of living, which thereby assesses both the social and
economic development of a nation. Human devel-
opment indexes are now also available for subgroups
within a country. These subgroup-specific, or
disaggregated, human development indexes include
geographical regions, gender, and ethnicity10–12 and
are used to highlight the stark disparities and
inequalities that exist across subgroups.13 The
human development index is used to study the rates
of infant mortality, depression, infectious diseases,
dental caries, and malnutrition.11,14–20 It is sug-
gested that the human development index may
correlate with access to cardiac surgery (Dr Luis
Alesandro Larrazabal, personal communication),
although its relationship with congenital heart
disease detection remains to be explored.
The Unidad’s unique position as the nation’s only
referral centre renders Guatemala an ideal country
in which to study the epidemiology of congenital
heart disease detection in the developing world.
By studying the Unidad’s referral patterns, one
can evaluate congenital heart disease detection for
the entire country and each of its regions. More
importantly, the Unidad can provide specialised
therapy for the Guatemalan children who are
diagnosed with cardiac defects so that interventions
directed at improving the detection rate can lead to
significantly improved outcomes. The first aim of
this study was to determine the rate and timing
of congenital heart disease detection in Guatemala,
by comparing the rate of congenital heart disease
and the age at presentation to the Unidad with
the expected incidence. The second aim was to
determine whether the regional human develop-
ment index correlates with the regional congenital
heart disease detection rates in Guatemala. For this
purpose, we compared the congenital heart disease
detection rate and the human development index for
each of the 22 regions in Guatemala.
Methods
Expected incidence of congenital heart disease
To estimate the annual incidence of congenital heart
disease in Guatemala, we obtained birth rates for
each of the 22 regions in Guatemala from the
National Ministry of Health database. We averaged
birth rates obtained over the past 10 years in order
to eliminate error caused by annual fluctuations.
Eliminating this error was particularly important
because our detection protocol included children of
various ages, so that their birth dates were not
linked to the year of study. We then calculated the
expected number of children born with congenital
heart disease in Guatemala each year, using an
incidence of 10 per 1000 live births.1–4 In addition,
the expected number of children born with severe
cardiac lesions was calculated using an expected
incidence of 35 per 100 children with congenital
heart disease.1,3 We chose to estimate the incidence
rather than the prevalence of congenital heart
disease for multiple reasons. The prevalence of
congenital heart disease in Guatemala is extremely
difficult to determine when a large portion of the
population has limited access to health care, whereas
the incidence is relatively consistent across different
populations.1–4 Furthermore, our main focus was on
infants with severe cardiac lesions who would benefit
most from early detection, and thus incidence at birth
was more relevant to this study population.
Detection of congenital heart disease
In order to determine the current rate of congenital
heart disease detection in Guatemala, we retro-
spectively assessed the number of new referrals for
congenital heart disease made to the Unidad in
2006. Patients were included if they were 18 years
of age or under, were native to Guatemala, had
congenital heart disease, and were diagnosed in the
year 2006.
For patients who met the inclusion criteria, we
collected several variables via retrospective chart
review, including age at time of diagnosis, region of
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origin, specific cardiac diagnosis, and, when applic-
able, age at first intervention (therapeutic catheterisa-
tion or surgery) and outcome. We then compared the
number of congenital heart disease cases detected, per
region, with the expected incidence. This comparison
yielded the percentage of expected congenital heart
disease cases diagnosed per region, or the regional
congenital heart disease detection rate.
Correlation with the human development index
The human development index for each of the 22
regions in Guatemala was obtained from the published
United Nations 2006 Development Program Report.10
Statistical analysis
Analysis was performed using the Statistics Package
for Social Science Version 15. Categorical variables
were analysed with a chi-square statistic and interval
data with analysis of variance. The relationship
between the regional congenital heart disease detection
rate and regional human development index was
evaluated using Spearman’s rank correlation.
Institutional review board approval
This project was approved by the Institutional
Review Board, Committee on Human Research,
University of California (San Francisco, California,
United States of America). Data were entered into a
password-protected and encrypted database through
a joint Wiki webpage maintained by the Unidad
and the University of California.
Results
Expected incidence of congenital heart disease
The population in Guatemala in 2006 was
12,293,545. The overall birth rate, averaged over
the 10 preceding years, was 393,565, ranging from
4176 births in the region of El Progreso to 65,796
births in the region of Guatemala City. This yields
an estimated overall incidence of congenital heart
disease of 3935 live births per year in the country,
ranging from 41 infants in El Progreso to 657
children in Guatemala City. Of these, 1380 infants
(35%) were expected to have severe cardiac lesions
requiring surgical correction in the first year of life.
Detection of congenital heart disease
A total of 7,118 patients were seen at the Unidad in
2006, of which 832 were new referrals (Fig 1). Of
the new referrals, 21 were excluded for age over 18
years, and 12 were excluded for not being native
to Guatemala. Of the remaining 799 patients, 257
(32.2%) were excluded for having structurally
normal hearts and nine (1.1%) were excluded for
incomplete data – four died before diagnosis and
five had missing records. Patients with normal
cardiac anatomy were referred for reasons ranging
from evaluation of murmur to treatment of
arrhythmias and effusions (Fig 2). Therefore, only
533 children, an estimated 14% of all children with
congenital heart disease, were diagnosed in 2006
and subsequently analysed in our study.
New referrals with congenital heart disease
tended to be older at the time of diagnosis than
new congenital heart disease referrals seen in
developed countries.9 Only 3.9% of new cardiac
Figure 1.
Comparison of congenital heart disease referrals made to the
Unidad and expected congenital heart disease incidence for 2006.
Figure 2.
Distribution of new referrals with normal cardiac anatomy in
2006; *normal includes referrals for functional murmur, chest
pain, and syncope.
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referrals were diagnosed at less than 1 week of age and
11.5% at less than 1 month of age. There were 39%
who were diagnosed between 1 month and 1 year of
age, and 49.7% at greater than 1 year of age.
Older age at the time of diagnosis was found
across all congenital heart disease types (Table 1),
regardless of lesion severity. Only patients with
pulmonary atresia with intact ventricular septum
(1% of congenital heart disease), and those who
presented at the point of death and died before their
diagnosis being confirmed, had a median age of
diagnosis of less than 1 month. The majority of
patients were greater than 1 year of age, including
those with transposition of the great arteries, whose
median age of diagnosis was 14 months.
The distribution of congenital heart disease
diagnoses also differed from the distribution typi-
cally seen in developed countries in which simple
lesions were over-represented (Fig 3). Of the new
referrals with congenital heart disease, 62% had
simple shunt lesions, whereas only 1.5% had a
transposition of the great arteries, and 0.5% had
hypoplastic left heart syndrome. In developed
countries, 50% of patients with congenital heart
disease have simple shunt lesions, 3.2% have
transposition of the great arteries, and 2.8% have
hypoplastic left heart syndrome.3
The percentage of patients in Guatemala with
congenital heart disease who were actually detected
and referred to the Unidad varied greatly by region
(Fig 4a). The region surrounding Guatemala City
had the greatest congenital heart disease detection
rate (34% of that expected), whereas the regions of
Alta Verapaz and Izabal had the least (3.2% and
3.4% of that expected, respectively).
Congenital heart disease detection rate correlation
with the human development index
The percentage of patients with congenital heart
disease detected by region in Guatemala correlated
with the regional human development index
(r5 0.75, p, 0.0001; Fig 4b). When the region
of Guatemala City was excluded, the regional
congenital heart disease detection rate continued
to correlate with the regional human development
index (r5 0.72, p, 0.0001). Age at the time of
diagnosis and disease severity did not correlate with
the regional human development index. However,
regions with a higher human development index
did tend to have more patients referred for shunt
Table 1. Age at the time of diagnosis, according to specific diagnosis.
Category Diagnosis n (%) Median age (years) IQR (years)
Normal Normal 257 (32.2) 6.098 2.00–4.00
Simple ASD/PFO 56 (7) 2.0123 0.37–6.67
PDA 158 (19.8) 1.815 0.67–5.92
VSD 114 (14.3) 0.605 0.25–2.90
PS 27 (3.4) 0.578 0.14–4.55
AS-AI 23 (2.9) 6.334 1.26–11.0
TS-TR 6 (0.8) 6.065 4.02–7.75
MS-MR 8 (1) 6.723 3.86–11.0
PAPVR 6 (0.8) 3.738 0.77–6.03
Cardiomyopathy 5 (0.6) 10.336 9.35–12.0
Complex COA-IAA 26 (3.3) 0.292 0.12–3.02
TOF/DORV 28 (3.5) 0.738 0.18–4.36
Tricuspid Atresia 9 (1.1) 0.235 0.20–0.40
HLHS 3 (0.4) 0.093 0.05–0.16
TGA 10 (1.3) 1.189 0.15–1.19
TAPVR 14 (1.8) 0.282 0.19–1.20
AVCD 9 (1.1) 0.534 0.17–3.66
PA-IVS 5 (0.6) 0.041 0.01–0.06
Ebsteins 6 (0.8) 2.017 0.38–12.8
Truncus Arteriosus 4 (0.5) 0.171 0.11–2.11
Heterotaxy 9 (1.1) 0.983 0.17–5.08
Unknown Died, no diagnosis 4 (0.5) 0.045 0.01–3.56
Other Other 7 (0.9) 1.268 0.63–7.65
AS-AI5 aortic stenosis-aortic insufficiency; AVCD5 atrioventricular canal defect; COA-IAA5 coarctation-interrupted aortic arch;
HLHS5 hypoplastic left heart syndrome; IQR5 inter quartile range; MS-MR5mitral stenosis-mitral regurgitation; PA-IVS5 pulmonary
atresia with intact ventricular septum; PAPVR5 partial anomalous pulmonary venous return; PDA5 patent ductus arteriosus; PFO/
ASD5 patent foramen ovale/atrial septal defect; PS5 pulmonary stenosis; TAPVR5 total anomalous pulmonary venous return;
TGA5 transposition of the great arteries; TOF/DORV5 tetralogy of Fallot/double outlet right ventricle; TS-TR5 tricuspid stenosis-tricuspid
regurgitation; VSD5 ventricular septal defect
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Figure 3.
Expected and documented frequency of congenital heart disease diagnoses, as number of patients. Expected frequencies are obtained from
Hoffman and Kaplan3; AS5 aortic stenosis; ASD/PFO5 atrial septal defect/patent foramen ovale; AVCD5 atrioventricular canal
defect; COA-IAA5 coarctation-interrupted aortic arch; HLHS5 hypoplastic left heart syndrome; PA5 pulmonary atresia; PDA5
patent ductus arteriosus; PS5 pulmonary stenosis; TAPVR5 total anomalous pulmonary venous return; TGA5 transposition of the great
arteries; TOF5 tetralogy of Fallot; VSD5 ventricular septal defect.
Figure 4.
(a) Percentage of patients with congenital heart disease detected in the various regions of Guatemala. Congenital heart disease detected/
expected was 14% for Guatemala overall (b) Percentage of patients with congenital heart disease detected/expected versus human development
index by region in Guatemala. Congenital heart disease detected/expected was 14% for Guatemala overall. The human development index
for Guatemala overall in the year 2006 was 0.689; CHD5 congenital heart disease; HDI5 human development index.
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lesions (p. 0.05). All regions, regardless of the
human development index, had dramatically lower
levels of diagnosis of complex cardiac disease than
was expected.
Discussion
This study shows that the current rate of congenital
heart disease detection in Guatemala is very low,
despite the presence of a high-quality referral centre
for paediatric cardiac care at little or no cost. We
found that fewer than 14% of all Guatemalan
children with congenital heart disease were diag-
nosed. In addition, this study shows that region-
specific human development indexes correlate with
regional congenital heart disease detection rates in
Guatemala (r5 0.75, p, 0.0001).
From these data, we predict that the mortality
rate among Guatemalan neonates with complex
congenital heart disease is very high. Few patients
(11.5%) were diagnosed in the first month of life,
whereas in developed nations, over a third of
patients are diagnosed in the early newborn period.9
Furthermore, the majority of those diagnosed with
cardiac defects (62%) had simple shunt lesions.
Children with simple shunt lesions can survive
several years without intervention21–23 and for this
reason may be over-represented in our study. In
contrast, children with complex lesions require
surgery in the first year of life in order to survive.
For example, 95% of patients with transposition
of the great arteries die by the age of 1 year if
untreated.24,25 In developed countries, the majority
of transposition of the great arteries patients are
diagnosed in the early neonatal period, and have a
95% long-term survival rate following the arterial
switch operation.24,26 In Guatemala, the median age
of diagnosis for transposition of the great arteries
was 14 months. Therefore, given the incidence
of transposition of the great arteries and its late age
at diagnosis, it is reasonable to conclude that the
vast majority of neonates in Guatemala with this
common severe lesion die before diagnosis. In fact,
80% of the patients diagnosed with transposition of
the great arteries at the Unidad were found to have
additional lesions, such as ventricular septal defect,
which allowed them to survive despite the lack of
surgical treatment. In comparison, only 30% of
transposition of the great arteries in patients born in
developed nations have such additional lesions.27
Unfortunately, those who survive frequently develop
cardiac failure, pulmonary hypertension, and neu-
rologic injury, ultimately rendering a treatable
disease inoperable.
To prevent the high morbidity and mortality
resulting from missed and late diagnosis, the rate
and timing of congenital heart disease detection in
Guatemala needs to be improved. Obstacles con-
tributing to delayed cardiac surgery in Guatemala
include living in a rural area, living far from the
Unidad, and lacking access to primary medical
care.28 One way to overcome these obstacles is
through the development of foetal and neonatal
outreach programmes. In developed nations, such
programmes have led to earlier detection of
congenital heart disease, reduced neonatal mortality,
and improved outcomes.9,29–32 The oldest congeni-
tal heart disease outreach programme is the New
England Regional Infant Cardiac Program estab-
lished in 1969.9,33 This programme laid emphasis
on teaching nursery workers the signs of neonatal
congenital heart disease in addition to establishing
community contacts and referral infrastructure. In
only a few years, the New England Regional Infant
Cardiac Program increased the number of neonates
diagnosed with congenital heart disease within
the first 48 hours of life from 20% to 34%. In
comparison, currently only 3.9% of new congenital
heart disease referrals made in Guatemala were
diagnosed within 1 week of age. Thus, the develop-
ment of a targeted neonatal outreach programme
designed to teach healthcare workers the signs of
neonatal congenital heart disease may greatly improve
detection rates in Guatemala.
We suggest that the human development index
can be a useful tool in the development of a directed
neonatal outreach programme in Guatemala because
it correlates with regional congenital heart disease
detection rates. It is imperative that outreach
programmes are cost-effective and are designed to
render the greatest benefit to the most individuals. The
regional human development index correlates with
congenital heart disease detection rates and therefore
should be considered when exploring the cost/benefit
ratio of implementing a neonatal congenital heart
disease outreach programme. However, the regional
human development index did not correlate either
with age at the time of diagnosis or with lesion
severity. This lack of correlation may be explained by
the observation that regions with lower human
development indexes tended to have small sample
sizes, whereas regions with higher human development
indexes tended to have large sample sizes encompassing
more patients of every age and every lesion severity.
Our study has several limitations. Primarily, our
methods assume that the incidence of congenital
heart disease in Guatemala, along with the
frequency of specific lesions, is similar to that
found in other nations. Despite the incidence of
some specific lesions being found to be higher in
certain ethnic groups,34 most epidemiologic studies
have found a similar overall incidence of congenital
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heart disease across different countries.35,36 More
recently, Mangones et al37 reported that in one
region of New York, the prevalence of cardiac
lesions in Hispanic children less than 2 years of age
was lower than that found in other ethnic groups
(9/1000 vs. 12–14/1000). However, it is difficult to
determine how socio-economic factors may have
influenced these results and how the prevalence of
congenital heart disease in this group reflects
congenital heart disease incidence. Specifically, in
Guatemala, the frequency of cardiac lesions was
studied among children with Down syndrome
undergoing surgical repair at the Unidad.38 In this
subgroup, patent ductus arteriosus and ventricular
septal defects were found to be at a higher frequency
than atrioventricular canal defects, which are more
common among children in the United States
of America with Down syndrome. However, it is
unclear how many patients with Down syndrome
were missed in this study, and more importantly,
how these results relate to the overall frequency of
cardiac lesions in Guatemala.
Our estimate of congenital heart disease incidence
may further be flawed by factors that may impact
overall foetal survival in Guatemala, such as maternal
health and nutritional status, altitude, and genetic
isolation of certain ethnic subgroups. Unfortunately,
the lack of adequate data regarding regional
differences in foetal survival, maternal health, and
ethnicity prevented us from controlling for these
variables in our analysis. The error caused by these
factors, however, does not negate our primary finding
that the vast majority of infants with congenital
heart disease are not being diagnosed because the
overall detection rate calculated using our estimated
incidence was so low at only 14%.
Our methods secondly assume that detection and
treatment of congenital heart disease did not take
place outside of the Unidad. Despite the Unidad
being the only referral centre for the treatment
of cardiac lesions in Guatemala, a few patients do
have the financial means to seek medical treatment
abroad, whereas others rely on the treatment offered
by visiting medical teams. However, these patients
most likely comprise a very small portion of the
entire population and the error caused by their
exclusion is probably negligible. More importantly,
it is impossible to determine how many patients
may have been referred to the Unidad for treatment
and decided not to go because of cultural beliefs,
personal biases, or perceived financial burden on
the family.
Finally, this study is a retrospective review, and
thereby has intrinsic flaws, including its cross-
sectional nature and reliance on incomplete medical
records. However, it does provide the groundwork
needed to develop a prospective study to determine
the true incidence of congenital heart disease and
evaluate the impact of future neonatal outreach
programmes on early congenital heart disease
detection in Guatemala.
In summary, we found that the current rate of
congenital heart disease detection in Guatemala is
extremely low. Furthermore, those diagnosed with
congenital heart disease were found to be older and to
have simpler lesions than those typically seen in
developed nations, implying a high mortality rate
among neonates with complex cardiac defects. We
suggest that the implementation of outreach pro-
grammes educating healthcare workers on the neonatal
presentation of cardiac defects may improve the
current rate of congenital heart disease detection
in Guatemala. Finally, we show a strong statistical
correlation between congenital heart disease detection
rates and the region-specific human development
index. The cause and clinical importance of this
relationship, and most importantly, the implication
for intervention, require further exploration. Our
current study supports the concept that regional
human development indexes may be a useful tool in
understanding the cost/benefit ratio in targeting
specific regions in Guatemala when developing future
neonatal outreach programmes.
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